Dr.Reddy's Apremilast API and finished formulation offerings.
Apremilast, is an anti-inflammatory agent modulating a wide range of inflammatory mediators in psoriasis and psoriatic arthritis. Apremilast is indicated for the treatment of active psoriatic arthritis and moderate to severe plaque psoriasis.
Dr. Reddy's amorphous API has been successfully formulated into drug products by various formulators with successful bioequivalence studies and subsequent dossier filing.
To know more about our offerings , please read the technical sheet on Apremilast by filling the contact from below.
Explore other Whitepapers:Know More
Please fill the Contact form below in order to view the white paper